Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

AGENT IDE: A Prospective, Randomized (2:1), Multicenter Trial to Assess the Safety and Effectiveness of the AgentTM Paclitaxel Coated PTCA Balloon Catheter for the Treatment of Subjects With In-Stent Restenosis (ISR)

NCT04647253 is registered in ClinicalTrials.gov with Boston Scientific Corporation as lead sponsor.

NCT NCT04647253
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04647253 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
AGENT IDE: A Prospective, Randomized (2:1), Multicenter Trial to Assess the Safety and Effectiveness of the AgentTM Paclitaxel Coated PTCA Balloon Catheter for the Treatment of Subjects With In-Stent Restenosis (ISR)
Lead sponsor
Boston Scientific Corporation
Phase
Phase 3
Overall status
Active, not recruiting
Start date
May 11, 2021
Completion date
September 30, 2027
Enrollment
600 (actual)
Sites
40

Conditions

As the registry lists them; a condition with its own page is linked.

in-stent restenosis